Supplements
fatty fish decreases inflammation
In plain terms: Does fish help with inflammation or arthritis?
Part of: • Fatty fish
Two answers. Eating fish shows a weak, inconsistent link to lower risk of developing rheumatoid arthritis. But concentrated omega-3s (supplement doses) fairly reliably ease RA symptoms - joint tenderness and pain - in people who already have it, even if they don't move inflammation blood tests much.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
For rheumatoid arthritis, the evidence has two layers. Eating fish shows a modest, somewhat inconsistent link to lower RA risk in cohort studies (some clearly null, e.g. the Nurses' Health Study). Meanwhile, omega-3 supplement trials fairly consistently improve RA symptoms — tender joints, pain, disease-activity scores — though they move blood inflammatory markers (CRP) less reliably.
The evidence (25)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Asoudeh F et al. 2021 · Adv Nutr | meta-analysis | supports | moderate | SR+dose-response meta 13 studies: highest vs lowest fish inversely associated with RA risk (RR 0.89). |
| Kęska M et al 2026 · study_type: observational | observational | supports | low | Narrative review of fish-oil-containing lipid emulsions in parenteral nutrition for critically ill patients; cites meta-analyses/trials suggesting reduced infection/sepsis risk and improved outcomes via immunomodulatory, pro-resolving media |
| Tedeschi SK et al. 2018 · Arthritis Care Res | observational | supports | low | Cross-sectional RA cohort: fish >=2x/week associated with lower disease activity (DAS28-CRP). |
| Xu Y et al. 2025 · Clin Nutr | meta-analysis | supports | moderate | Meta 24 RCTs: fatty-acid SUPPLEMENTATION improved DAS28, tender joint count, HAQ in RA. |
| Di Giuseppe D et al. 2014 · Arthritis Res Ther | meta-analysis | tested-null | moderate | Dose-response meta 7 studies: non-significant inverse (RR 0.96/serving); stronger inverse at 1-3 servings/wk (RR 0.76). |
| Nguyen Y et al. 2020 · Nutrients | observational | mixed | moderate | E3N-EPIC: MedDiet (incl fish) not associated with RA overall; protective only among ever-smokers. |
| Jurek JM et al 2026 · study_type: animal | meta-analysis | supports | moderate | Systematic review of 7 RCTs (2020-2026) in MASLD adults; fish oil and omega-3 supplementation led to modest improvements in lipid and hepatic (inflammation-adjacent) markers, freshwater fish also beneficial for glycemic/lipid control. |
| Al-Muzafar HM et al 2026 · study_type: animal | animal | supports | moderate | Rat model of diet-induced hypercholesterolemia (n=80); fish oil supplementation ameliorated elevated inflammatory markers (TNF, CRP) and endothelial dysfunction markers vs the high-cholesterol-diet-only group. |
| Chataigner M et al 2026 · study_type: RCT | RCT | supports | moderate | Double-blind RCT, 53 healthy elderly adults; 3 months of fish hydrolysate (1g peptides + 30mg n-3 PUFA/day) significantly reduced serum CRP (p=0.038) and an inflammation status score (p=0.046) vs placebo, alongside improved memory. |
| Wang R et al 2026 · study_type: animal | animal | mixed | moderate | Obese Wistar rats fed LCPUFA/fish-oil diets from weeks 3-10; fish oil and DHA diets lowered plasma CRP and some IL-8, but also lowered anti-inflammatory IL-10 in mesenteric lymph nodes and increased IL-8 in adipose tissue in a sex-specific |
| Dimopoulou M et al 2026 · study_type: observational | observational | supports | low | Systematic review (PubMed/Web of Science/Scopus/Cochrane through Nov 2025) explicitly aimed at omega-3 PUFA's potential to reduce inflammatory markers; concludes higher PUFA intake in older adults associates with better cardiovascular/cogni |
| Dimopoulou M et al 2026 · study_type: observational | observational | supports | low | Narrative review of omega-3 marine supplements/enhanced foods in children; states omega-3 fatty acids 'exhibit anti-inflammatory properties' and may improve metabolic health, though effects on outcomes are described as mixed/inconsistent. |
| Nguyen Y et al. 2022 · Arthritis Care Res | observational | mixed | moderate | E3N cohort: no linear association; moderate fish consumption (tertile 2) HR 0.74 for RA. |
| Hong Y et al. 2024 · Nutrients | meta-analysis | mixed | moderate | Umbrella + Mendelian randomization: consistent evidence omega-3 benefits RA (risk, activity, inflammation). |
| Di Giuseppe D et al. 2014 · Ann Rheum Dis | observational | supports | moderate | Swedish Mammography Cohort: long-chain n-3 >0.21 g/d associated with 52% decreased RA risk. |
| Giorgini G et al 2026 · study_type: animal | animal | supports | moderate | Mouse DSS-colitis model; fish oil (FO) and seal oil (SO), both n-3 PUFA-rich, reduced inflammatory markers (Il1b, Il6, Tnfa, Arg1) vs untreated colitis controls, with seal oil more efficacious than fish oil. |
| Rodziewicz A et al 2026 · study_type: observational | observational | supports | low | Narrative review of diet and microbiome in rheumatoid arthritis; identifies fish consumption and fish oil (EPA/DHA) among the most-researched dietary interventions shown to influence RA disease activity and inflammatory status. |
| Gkiouras K et al. 2022 · Clin Rheumatol | meta-analysis | mixed | moderate | Meta 23 RCTs: small, low-certainty effect of omega-3 SUPPLEMENTS on pain/joint counts; limited clinical benefit. |
| Patterson GE et al 2026 · study_type: animal | animal | supports | moderate | Mouse model of moderate acute malnutrition; replacing dietary corn oil with fish oil (n-3 rich) improved gut barrier function and dampened systemic inflammation vs the omega-6-rich control diet. |
| Benito-Garcia E et al. 2007 · Arthritis Res Ther | observational | tested-null | high | Nurses' Health Study (82k): no association between fish and RA risk. |
| Alzubi A et al 2026 · study_type: observational | observational | supports | low | Narrative review synthesizing mechanistic/clinical trial evidence that long-chain n-3 PUFAs (EPA/DHA) attenuate obesity-associated adipose tissue and skeletal muscle inflammation and inflammatory mediator production. |
| Sigaux J et al. 2022 · Joint Bone Spine | meta-analysis | supports | moderate | Meta 30 RCTs: omega-3 SUPPLEMENTS (>2 g/d animal source) improved pain, joint counts, DAS28, HAQ in inflammatory rheumatic disease. |
| Dong Y et al. 2024 · Front Nutr | meta-analysis | supports | low | Dose-response meta 30 studies (~3M): nonlinear inverse association between oily fish intake and RA risk. |
| Curry SA et al 2026 · study_type: animal | animal | supports | low | Heat-stressed wether lambs; fish oil capsules or omega-3 PUFA salts partially or fully resolved heat-stress-induced deficits in lipid mobilization linked to systemic inflammation, though effects were incomplete and outcome measures were lip |
| Tani S et al 2026 · study_type: observational | observational | supports | moderate | Cross-sectional study of 8675 adults; higher fish intake was significantly associated with lower systemic immune-inflammation index (SII, p<0.0001), with n-3 PUFA intake mediating much of the association. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.